New device aims to keep ICU Patients' muscles strong

NCT ID NCT07362862

Recruiting now Disease control Sponsor: Health Discovery Labs Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study tests whether a device called MyokinE100, which sends electrical signals to the thigh muscles, is safe and practical for use in the ICU. It includes 50 critically ill patients with sepsis who are at risk of muscle weakness. Half will receive standard care plus daily 60-minute sessions of electrical stimulation, while the other half gets standard care alone. Researchers will monitor for side effects and measure muscle strength changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MyokinE100 electrical muscle stimulation device
What this could lead to: If successful, this device could help ICU patients maintain muscle strength and recover faster, reducing long-term disability.
What could go wrong: This is an early feasibility study with only 50 participants, so results may not apply broadly. The device may cause discomfort or skin irritation, and it is not yet proven to prevent weakness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness critical illness polyneuropathy infectious disease with sepsis Sarcopenia Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS ICU ACQUIRED WEAKNESS ICU-ACQUIRED MUSCLE WEAKNESS ICUAW SARCOPENIA SECONDARY SARCOPENIA SEPSIS

Contacts and locations

Locations

Ascension Seton Medical Center Austin
RECRUITING

Austin, Texas, 78705, United States
Dell Seton Medical Center at The University of Texas
RECRUITING

Austin, Texas, 78701, United States
Mayo Clinic
RECRUITING

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.